Table 1 Patient characteristics
Characteristics | Number of patients n = 36, n (%) |
|---|---|
Age (years) | |
 Median | 54 |
 Range | (15–79) |
Gender | |
 Male | 14 (39%) |
 Female | 22 (61%) |
Race | |
 White/Caucasian | 28 (78%) |
 Black/African-America | 4 (11%) |
 Other | 4 (11%) |
Smoking | |
 Active or history of smoking | 18 (50%) |
 Never smoker | 18 (50%) |
ECOG performance status | |
 0 | 1 (3%) |
 1 | 30 (83%) |
 2 | 5 (14%) |
Tumor type | |
 Head and neck squamous cell carcinoma | 10 (28%) |
 Cervical cancer | 10 (28%) |
 Thyroid follicular carcinoma | 4 (11%) |
 Breast cancer | 3 (8%) |
 Pancreatic cancer | 3 (8%) |
 Salivary glands cancer | 2 (6%) |
 Bladder urothelial carcinoma | 2 (6%) |
 Sarcoma | 1 (3%) |
 Vulvar cancer | 1 (3%) |
 Squamous cell carcinoma of the skin | 1 (3%) |
Number of prior systemic therapies | |
 Median | 3 |
 Range | 1–10 |
Prior systemic treatment with anti-EGFR | 8 (22%) |
Prior systemic treatment with anti-VEGF | 9 (25%) |
Prior systemic treatment with anti-EGFR and anti-VEGF (sequential) | 2 (6%) |